Ascent Wealth Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Ascent Wealth Partners's NVS Position: Q3 2026 in Review
Ascent Wealth Partners increased its Novartis (NVS) stake by 1.5% in Q3 2026, buying an estimated $36.6K and bringing the position to 16,714 shares worth $2.38M. The position accounts for 0.24% of the portfolio, ranked #88.
Ascent Wealth Partners first reported a position in NVS in Q2 2021 and has held it in 22 quarters since. The position peaked at $2.58M in Q2 2026. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Ascent Wealth Partners held 16,714 shares of Novartis worth $2.38M as of Q3 2026.
- Ascent Wealth Partners bought 241 Novartis shares in Q3 2026, an estimated $36.6K.
- Novartis made up 0.24% of Ascent Wealth Partners's portfolio in Q3 2026, its #88 holding.
- Ascent Wealth Partners first reported a position in Novartis in Q2 2021 and has held it in 22 quarters since.
- Ascent Wealth Partners's Novartis position peaked at $2.58M in Q2 2026.
- 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Ascent Wealth Partners's 13F filing for Q3 2026, filed 23 Oct 2026.